Join us as we dive deeper into a graphic novelesque experience that sheds light on alchemy, chemistry, and the money that paid for it ...

Oxford Nanopore Technologies plc ( ONTTF) Q4 2025 Earnings Call March 2, 2026 5:45 AM EST Good morning, everyone, and thank you for joining us today. Before we move into the 2025 results presentation, ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

CHICAGO, IL, UNITED STATES, March 4, 2026 /EINPresswire.com/ -- At Chicago Waldorf High School (CWHS), senior year is ...

Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by ...

These posters and presentation represent a collaborative effort between Caris and over 20 cancer centers and institutions across the United States and Europe. “USCAP offers a great opportunity for ...

Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 Preparing to initiate Company's first-in-human clinic ...

COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology platform, provides business up ...

IF TIMING IS everything, then Thomas Hartung picked a bad moment to make his move. Dr Hartung is an environmental toxicologist at Johns Hopkins University, in Baltimore, who has spent his career ...

Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint for these cells is essentially the same. Where do those differences come ...